Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
APCDD1
REST API REST API
Homo sapiens
APCDD1 is differentially expressed in 139 experiments: 70 organism parts: bone marrow, liver, ... (68 more);, 53 disease states: normal, colorectal adenocarcinoma, ... (51 more);, 47 cell types 257 cell lines 24 compound treatments and 43 other conditions.
Synonyms B7323
Orthologs A1L562_BOVIN (Bos taurus)   ENSCING00000011767 (Ciona intestinalis)   APCD1_CHICK (Gallus gallus)   Apcdd1 (Mus musculus)   Apcdd1 (Rattus norvegicus)   apcdd1 (Xenopus laevis)   APCDD1 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term plasma membrane, negative regulation of Wnt receptor signaling pathway, Wnt-protein binding, integral to plasma membrane, hair follicle development
UniProt Accession Q8J025
Gene-Disease Assocation HYPOTRICHOSIS 1; HYPT1
Search EB-eye ENSG00000154856
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-17189, E-AFMX-5, E-GEOD-803, E-GEOD-6573, E-GEOD-7224, ... (16 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-14464, E-GEOD-19639, E-GEOD-24147, E-GEOD-19480, E-MEXP-903, ... (18 experiments)

Factor Value U/D Experiments
A549
2
 E-GEOD-3202, E-GEOD-6013
LNCaP
2
 E-GEOD-14990, E-GEOD-14464
MCF-7
2
 E-GEOD-20081, E-GEOD-19639
CAL54
1
 E-MTAB-37
NCIH1975
1
 E-MTAB-37
MDAMB453
1
 E-MTAB-37
251 more value(s).


Cell type

studied in E-MEXP-1242, E-GEOD-18811, E-AFMX-5, E-GEOD-21668, E-GEOD-20033, ... (21 experiments)

Factor Value U/D Experiments
human embryonic stem cell
2
 E-GEOD-18265, E-GEOD-20033
partially reprogrammed human induced pluripotent stem cell
2
 E-GEOD-18265, E-GEOD-18147
immortalised T lymphocytes
1
 E-GEOD-13909
endothelial cell
1
 E-GEOD-19240
BDCA1+ dendritic cell
1
 E-TABM-34
CD14+ CD16- peripheral blood monocyte
1
 E-MEXP-1242
41 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-MEXP-1121, E-MEXP-2069, E-GEOD-16363, ... (25 experiments)

Factor Value U/D Experiments
control
2
 E-GEOD-21912, E-GEOD-16363
Hodgkin lymphoma
1
 E-MTAB-37
B-cell neoplasm
1
 E-MTAB-37
juvenile dermatomyositis
1
 E-GEOD-3307
breast cancer
1
 E-GEOD-22544
gastric adenocarcinoma
1
 E-GEOD-15460
47 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-3284, E-GEOD-5741, E-GEOD-7216, E-GEOD-5099, ... (11 experiments)

Factor Value U/D Experiments
control
1
 E-GEOD-3284
control - keratinocyte growth factor
1
 E-GEOD-7216
M-CSF
1
 E-GEOD-5099
interleukin-24 (Homo sapiens)
1
 E-GEOD-7216
LDL
1
 E-GEOD-5741
control - untreated
1
 E-GEOD-7216
18 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
 E-GEOD-19519
tunicamycin
1
 E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-TABM-176, E-GEOD-19348, E-GEOD-19246, ... (8 experiments)

Clinical treatment
studied in E-GEOD-6532, E-GEOD-21610

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-5999, E-MEXP-2283

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-GEOD-19665

Estrogen receptor status
studied in E-GEOD-6532

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-20847

Genotype
studied in E-GEOD-17476, E-MEXP-421, E-TABM-868, E-GEOD-17347

Growth condition
studied in E-MEXP-2657, E-TABM-127, E-GEOD-20504, E-MEXP-1741, E-TABM-440, ... (6 experiments)

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-176, E-MEXP-2069, E-GEOD-19330, ... (18 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-17400

Injury
studied in E-GEOD-19743

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-19703, E-GEOD-1657

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-19445

RNAi
studied in E-MEXP-2115, E-MEXP-1857, E-MEXP-2759

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-18995

Sex
studied in E-GEOD-2508, E-GEOD-7307

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Treatment
studied in E-GEOD-33562, E-GEOD-19246

Processing time: 0.421 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM